Trimodal Therapy Approaches for Localized Rectal Cancer

被引:0
作者
Willett, Christopher G. [1 ]
机构
[1] Duke Canc Inst, Dept Radiat Oncol, 30 Duke Med Circle,Room 05143 Morris,Box 3085, Durham, NC 27710 USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2020年 / 18卷 / 07期
关键词
ADJUVANT CHEMOTHERAPY USE; PREOPERATIVE RADIOTHERAPY; RANDOMIZED-TRIAL; CHEMORADIOTHERAPY; CHEMORADIATION; PRESERVATION; MULTICENTER; RECURRENCE; SURVIVAL;
D O I
10.6004/jnccn.2020.5015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Excellent long-term outcomes and manageable toxicity are being achieved with contemporary treatment strategies for rectal cancer. Short-course radiotherapy is now an acceptable standard. Total neoadjuvant therapy (TNT), which incorporates induction or consolidation chemotherapy, has improved the delivery of treatment regiments. TNT is now a standard of care, although the sequencing of radiation and chemotherapy in TNT, appropriate amount of chemotherapy in TNT, and addition of irinotecan to the regimen are still being debated. Nonoperative management of rectal cancer appears to be a safe option for select patients, but it is not yet an NCCN recommendation. In addition, the omission of radiation is being evaluated as a treatment option in some cases.
引用
收藏
页码:954 / 957
页数:4
相关论文
共 24 条
  • [1] High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
    Appelt, Ane L.
    Ploen, John
    Harling, Henrik
    Jensen, Frank S.
    Jensen, Lars H.
    Jorgensen, Jens C. R.
    Lindebjerg, Jan
    Rafaelsen, Soren R.
    Jakobsen, Anders
    [J]. LANCET ONCOLOGY, 2015, 16 (08) : 919 - 927
  • [2] Benson AB, 2020, NCCN CLIN PRACTICE G
  • [3] Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
    Bosset, Jean-Francois
    Calais, Gilles
    Mineur, Laurent
    Maingon, Philippe
    Stojanovic-Rundic, Suzana
    Bensadoun, Rene-Jean
    Bardet, Etienne
    Beny, Alexander
    Ollier, Jean-Claude
    Bolla, Michel
    Marchal, Dominique
    Van Laethem, Jean-Luc
    Klein, Vincent
    Giralt, Jordi
    Clavere, Pierre
    Glanzmann, Christoph
    Cellier, Patrice
    Collette, Laurence
    [J]. LANCET ONCOLOGY, 2014, 15 (02) : 184 - 190
  • [4] Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
    Bujko, K.
    Wyrwicz, L.
    Rutkowski, A.
    Malinowska, M.
    Pietrzak, L.
    Krynski, J.
    Michalski, W.
    Oledzki, J.
    Kusnierz, J.
    Zajac, L.
    Bednarczyk, M.
    Szczepkowski, M.
    Tarnowski, W.
    Kosakowska, E.
    Zwolinski, J.
    Winiarek, M.
    Wisniowska, K.
    Partycki, M.
    Beczkowska, K.
    Polkowski, W.
    Stylinski, R.
    Wierzbicki, R.
    Bury, P.
    Jankiewicz, M.
    Paprota, K.
    Lewicka, M.
    Cisel, B.
    Skorzewska, M.
    Mielko, J.
    Bebenek, M.
    Maciejczyk, A.
    Kapturkiewicz, B.
    Dybko, A.
    Hajac, L.
    Wojnar, A.
    Lesniak, T.
    Zygulska, J.
    Jantner, D.
    Chudyba, E.
    Zegarski, W.
    Las-Jankowska, M.
    Jankowski, M.
    Kolodziejski, L.
    Radkowski, A.
    Zelazowska-Omiotek, U.
    Czeremszynska, B.
    Kepka, L.
    Kolb-Sielecki, J.
    Toczko, Z.
    Fedorowicz, Z.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (05) : 834 - 842
  • [5] Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy
    Bujko, K
    Nowacki, MP
    Nasierowska-Guttmejer, A
    Michalski, W
    Bebenek, AB
    Pudelko, M
    Kryj, A
    Oledzki, J
    Szmeja, J
    Sluszniak, J
    Serkies, K
    Kladny, J
    Pamucka, A
    Kukolowicz, P
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 72 (01) : 15 - 24
  • [6] Long-course preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study
    Cisel, B.
    Pietrzak, L.
    Michalski, W.
    Wyrwicz, L.
    Rutkowski, A.
    Kosakowska, E.
    Cencelewicz, A.
    Spalek, M.
    Polkowski, W.
    Jankiewicz, M.
    Stylinski, R.
    Bebenek, M.
    Kapturkiewicz, B.
    Maciejczyk, A.
    Sadowski, J.
    Zygulska, J.
    Zegarski, W.
    Jankowski, M.
    Las-Jankowska, M.
    Toczko, Z.
    Zelazowska-Omiotek, U.
    Kepka, L.
    Socha, J.
    Wasilewska-Tesluk, E.
    Markiewicz, W.
    Kladny, J.
    Majewski, A.
    Kapuscinski, W.
    Suwinski, R.
    Bujko, K.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (08) : 1298 - 1303
  • [7] Conroy T, 2020, ASCO 2020 ANN M MAY
  • [8] Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
    Erlandsson, Johan
    Holm, Torbjorn
    Pettersson, David
    Berglund, Ake
    Cedermark, Bjorn
    Radu, Calin
    Johansson, Hemming
    Machado, Mikael
    Hjern, Fredrik
    Hallbook, Olof
    Syk, Ingvar
    Glimelius, Bengt
    Martling, Anna
    [J]. LANCET ONCOLOGY, 2017, 18 (03) : 336 - 346
  • [9] Fokas Emmanouil, 2019, J Clin Oncol, V37, P3212, DOI 10.1200/JCO.19.00308
  • [10] Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
    Gao, Peng
    Huang, Xuan-zhang
    Song, Yong-xi
    Sun, Jing-xu
    Chen, Xiao-wan
    Sun, Yu
    Jiang, Yu-meng
    Wang, Zhen-ning
    [J]. BMC CANCER, 2018, 18